ASCO 2020: Low-Risk Pediatric A-LL Patients Fare Extremely Well With Reduced Intensity Treatment
Disease-free survival at 5 years exceeded 98%, provided patients were stringently selected
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.